Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-138
Closed -$6K 332
2018
Q2
$6K Hold
138
﹤0.01% 258
2018
Q1
$6K Hold
138
﹤0.01% 285
2017
Q4
$6K Buy
+138
New +$6.36K ﹤0.01% 250
2017
Q1
Sell
-356
Closed -$14K 348
2016
Q4
$14K Buy
356
+156
+78% +$6.15K 0.01% 231
2016
Q3
$8K Sell
200
-136
-40% -$5.46K ﹤0.01% 261
2016
Q2
$14K Buy
336
+74
+28% +$3.03K ﹤0.01% 225
2016
Q1
$11K Sell
262
-40
-13% -$1.61K ﹤0.01% 233
2015
Q4
$13K Hold
302
﹤0.01% 229
2015
Q3
$14K Buy
+302
New +$15.4K 0.01% 219

Other funds holding SNY

Whitnell & Co's SNY Position: Q3 2018 in Review

Whitnell & Co sold out of Sanofi (SNY) in Q3 2018, closing a stake of 138 shares — an estimated $6K sold.

Whitnell & Co first reported a position in SNY in Q3 2015 and held it in 9 quarters. The position peaked at $14K in Q4 2016. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

  • Whitnell & Co reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
  • Whitnell & Co sold 138 Sanofi shares in Q3 2018, an estimated $6K.
  • Whitnell & Co first reported a position in Sanofi in Q3 2015 and held it in 9 quarters.
  • Whitnell & Co's Sanofi position peaked at $14K in Q4 2016.
  • 480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Whitnell & Co's 13F filing for Q3 2018, filed 23 Oct 2018.